Skip to main content
Signal8
Tucker Edwin Jonathan profile photo

Edwin Jonathan Tucker

CIK: 0001792296

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jun 4, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    90K shares-
  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Feb 13, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    50K shares-

1-2 of 2

About Tucker Edwin Jonathan

Tucker Edwin Jonathan (SEC CIK 0001792296) files insider reports with the SEC as Chief Medical Officer of Jasper Therapeutics, Inc. (JSPR).

Signal8 holds 2 ownership filings by Tucker Edwin Jonathan, all Form 4s, filed between Feb 18, 2025 and Jun 6, 2025. Those filings report 2 transactions, from Feb 13, 2025 to Jun 4, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Tucker Edwin Jonathan's filings is in REDWOOD CITY, CA.

Recent filings by Tucker Edwin Jonathan

  • Jun 4, 2025: Grant or award of JSPR derivative securities (Form 4, code A).
  • Feb 13, 2025: Grant or award of JSPR derivative securities (Form 4, code A).

Other insiders filing for Jasper Therapeutics, Inc. (JSPR)

How to read Form 4 transaction codes